Continuing Sodium Zirconium Cyclosilicate (SZC) after discharge study

Trial Identifier: D9480C00023
Sponsor: AstraZeneca
Start Date: March 2022
Primary Completion Date: December 2024
Study Completion Date: December 2024
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
BE Bonheiden, BE, 2820
BE Leuven, BE, 3000
ES Algeciras, ES, 11207
ES Almería, ES, 04009
ES Badajoz, ES, 06080
ES Barcelona, ES, 08907
ES Burgos, ES, 9006
ES Getafe, ES, 28905
ES Madrid, ES, 28007
ES Madrid, ES, 28040
ES Salamanca, ES, 37007
ES San Sebastián de los Reyes, ES, 28702
ES Sevilla, ES, 41009
ES Talavera de la Reina, ES, 45600
ES Zamora, ES, 49022
FR ANNONAY, FR, 07103
FR Ars-Laquenexy, FR, 57530
FR Nice, FR, 06000
FR SAINT-PRIEST EN JAREZ, FR, 42270
GB Doncaster, GB, DN2 5LT
GB Hull, GB, HU10 7AZ
GB Salford, GB, M6 8HD
GB Stevenage, GB, SG1 4AB
IT Bari, IT, 70120
IT Foggia, IT, 71122
IT Parma, IT, 43125
IT Pavia, IT, 27100
NL Eindhoven, NL, 5602 ZA